October 4, 2022October 17, 2023News Press Release: Biograil and Lilly Sign Collaboration and License Agreement Biograil has signed a Collaboration and License Agreement with Eli Lilly
March 14, 2022October 17, 2023News Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDDTM Technology Research and Activities in Preparations for Phase 1 clinical trials Biograil recieves granting of government funds from Innobooster
March 1, 2022October 17, 2023News Press Release: Biograil Forms International Scientific Advisory Board with Diverse Expertise to Support Further Optimization of the proprietary BIONDDTM Technology After achieving proof of concept of BIONDDTM Technology in a pre-clinical model
February 17, 2022October 17, 2023News Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics Biograil closing of a Seed 2 funding of 3.2 million Euro.
December 2, 2020October 17, 2023News Press Release: Biograil signs collaboration agreement with Janssen Biograil has signed a Feasibility, Option and License Agreement with Janssen Biotech, Inc.
April 30, 2020October 17, 2023News Press Release: Biograil announces – Sanner Ventures has joined Investor Syndicate Biograil closing of a seed funding of 3 Million Euro
April 8, 2020October 17, 2023News CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
January 15, 2020October 17, 2023News Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables Biograil closing of a seed funding of 3 Million Euro